Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study
Case seriesHumans
- Design
- Case series
- Subjects
- One 67-year-old man with post-herpetic neuralgia of 3 years' duration after shingles
- Dose used in the study
- Palmitoylethanolamide 900 mg daily (10 mg/kg)
- Duration
- Pain relief reported within 48 hours; total duration not stated
- What was measured
- Pain relief in a single patient; earlier studies on PEA and neuropathy were reviewed to discuss possible mechanisms.
What the authors reported
Pain relief was effective within 48 hours of starting palmitoylethanolamide at 900 mg per day, the author reports.
Limits of this study
A single case report with no control, no blinding and no stated outcome scale; it cannot show that PEA caused the improvement or that it applies to others. Funding and conflicts not stated in the abstract.
Source
PubMed 34289728 · doi:10.1177/02601060211019669
Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.